-Takashi Yoshimoto Researcher Activity Profile

Research Author Detailed Information 

Takashi Yoshimoto Publication Rate By Year

Takashi Yoshimoto has published 1 paper(s) in 1973, 1 paper(s) in 1974, 1 paper(s) in 1975, 2 paper(s) in 1976, 1 paper(s) in 1977, 1 paper(s) in 1979, 1 paper(s) in 1980, 3 paper(s) in 1982, 2 paper(s) in 1983, 2 paper(s) in 1984, 2 paper(s) in 1985, 2 paper(s) in 1986, 1 paper(s) in 1988, 4 paper(s) in 1989, 2 paper(s) in 1990, 1 paper(s) in 1991, 2 paper(s) in 1992, 3 paper(s) in 1993, 5 paper(s) in 1995, 2 paper(s) in 1996, 1 paper(s) in 1997, 3 paper(s) in 1998, 3 paper(s) in 1999, 6 paper(s) in 2000, 2 paper(s) in 2001, 3 paper(s) in 2003, 6 paper(s) in 2004, 1 paper(s) in 2005, 3 paper(s) in 2006, 17 paper(s) in 2007, 11 paper(s) in 2008, for a total of 95 research publications in total.

Takashi T Yoshimoto Author Information

LAST NAME: yoshimoto

FIRST NAME: Takashi

INITIALS: t

AFFILIATION:

Papers

Takashi Yoshimoto's Publication Record

1. Radiological findings, clinical course, and outcome in asymptomatic moyamoya disease: results of multicenter survey in Japan. Year Published: 2007
Department of Neurosurgery, Hokkaido University Graduate School of Medicine, Kita-ku, Sapporo, Japan. skuroda@med.hokudai.ac.jp
2. Hypoxia-mediated induction of heme oxygenase type I and carbon monoxide release from astrocytes protects nearby cerebral neurons from hypoxia-mediated apoptosis. Year Published: 2007
Department of Medicine, Seiwa Hospital, Osaka, Japan.
3. PTEN gene mutation and high MIB-1 labeling index may contribute to dissemination in patients with glioblastoma. Year Published: 2003
Department of Neurosurgery, Tohoku University Graduate School of Medicine, Sendai, Japan.
4. Neuromagnetic separation of secondarily bilateral synchronized spike foci: report of three cases. Year Published: 2004
Neurology Department, Neurologic Institute, Taipei Veterans General Hospital, Taipei, Taiwan.
5. Preoperative visualization of microvascular compression of cranial nerve IX using constructive interference in steady state magnetic resonance imaging in glossopharyngeal neuralgia. Year Published: 2004
Department of Neurosurgery, Tohoku University Graduate School of Medicine, Aoba-ku, Sendai, Japan. karibe@nsg.med.tohoku.ac.jp
6. Use of porous hydroxyapatite graft containing recombinant human bone morphogenetic protein-2 for cervical fusion in a caprine model. Year Published: 1999
Department of Neurosurgery, Tohoku University School of Medicine, Sendai, Japan.
7. Endothelin-1 induces cyclooxygenase-2 expression and generation of reactive oxygen species in endothelial cells. Year Published: 2005
*Department of Clinical and Molecular Endocrinology, Tokyo Medical and Dental University Graduate School, Tokyo, Japan.
8. Extrahepatic manifestations in transgenic mice of osteopontin in hepatocytes-A clue to advent of pathological state in various organs of chronic hepatitis C patients. Year Published: 2006
Division of Gastroenterology & Hepatology, Internal Medicine, Saitama Medical School, 38 Morohongo, Moroyama-cho, Iruma-gun, Saitama 350-0495, Japan.
9. Increased cytoprotective function in the liver of transgenic mice expressing osteopontin in hepatocytes. Year Published: 2006
Division of Gastroenterology & Hepatology, Internal Medicine, Saitama Medical School, 38 Morohongo, Moroyama-cho, Iruma-gun, Saitama 350-0495, Japan.
10. Role of basic fibroblast growth factor in the pathogenesis of moyamoya disease. Year Published: 2006
Departments of Neurosurgery, Second Pathology, Second Anatomy, Hokkaido University School of Medicine, Sapporo, Japan; and Department of Neurosurgery, Kushiro Rousai Hospital, Kushiro, Japan.
11. Immunohistochemical detection of the lymphatic marker podoplanin in diverse types of human cancer cells using a novel antibody. Year Published: 2007
Molecular and Cancer Research Unit, HMRO, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
12. Specific genetic characteristics in patients with familial moyamoya disease. Year Published: 2007
Division of Neurosurgery, Tohoku Graduate School of Medicine, Miyagi, Japan.
13. High-resolution analysis of DNA copy number alterations and gene expression in renal clear cell carcinoma. Year Published: 2007
Department of Molecular Pathology, Faculty of Medicine, Oita University, Oita, Japan.
14. Suppression of prostaglandin E(2)-mediated c-fos mRNA induction by interleukin-4 in murine macrophages. Year Published: 2000
Department of Pharmacology, Kanazawa University School of Medicine, Kanazawa 920-8640, Japan.
15. Glutamate 83 is important for stabilization of domain-domain conformation of Thermus aquaticus glycerol kinase. Year Published: 2000
School of Pharmaceutical Sciences, Nagasaki University, Bunkyo-machi, Nagasaki 852-8521, Japan.
16. Substrate recognition mechanism of prolyl aminopeptidase from Serratia marcescens. Year Published: 2000
School of Pharmaceutical Sciences, Nagasaki University, Bunkyo-machi, Nagasaki 852-8521, Japan.
17. Directed evolution to improve the thermostability of prolyl endopeptidase. Year Published: 2000
Takarazuka Research Institute, Novartis Pharma K.K., Takarazuka, Hyogo 665, Japan. huchiyam@rs.noda.sut.ac.jp
18. Studies on bacteriolytic enzymes. II. Purification and some properties of two types of staphylolytic enzymes from Streptomyces griseus. Year Published: 1973
19. Inactivation of Rhizopus chinensis acid protease by some diazo compounds. Year Published: 1974
20. Affinity chromatography of lysozyme on a sepharose derivative coupled with lysozyme lysate of bacterial cell wall. Year Published: 1975
21. Purification of several bacteriolytic enzymes by affinity chromatography on lysozyme-lysate of Micrococcus lysodeikticus cell wall coupled with sepharose. Year Published: 1976
22. Purification, crystallization, and some properties of creatine amidinohydrolase from Pseudomonas putida. Year Published: 1976
23. Affinity chromatographic purification of human lysozyme, with special reference to human leukemia lysozyme. Year Published: 1977
24. Formaldehyde dehydrogenase from Pseudomonas putida. Purification and some properties. Year Published: 1979
25. Creatinine amidohydrolase (creatininase) from Pseudomonas putida. Purification and some properties. Year Published: 1980
26. Post-proline cleaving enzyme from lamb brain. Year Published: 1982
27. Proline-specific dipeptidyl aminopeptidase from Flavobacterium meningosepticum. Year Published: 1982
28. Dipeptidyl aminopeptidase IV from porcine pancreas. Year Published: 1982
29. Proline iminopeptidase from Bacillus megaterium: purification and characterization. Year Published: 1983
30. Substrate specificity of aminopeptidase M: evidence that the commercial preparation is contaminated by dipeptidyl aminopeptidase IV and prolidase. Year Published: 1983
31. Post-proline cleaving enzyme (prolyl endopeptidase) from bovine brain. Year Published: 1984
32. Prolidase from bovine intestine: purification and characterization. Year Published: 1984
33. Proline iminopeptidase from Bacillus coagulans: purification and enzymatic properties. Year Published: 1985
34. Extracellular tyrosinase from Streptomyces sp. KY-453: purification and some enzymatic properties. Year Published: 1985
35. Comparison of inhibitory effects of prolinal-containing peptide derivatives on prolyl endopeptidases from bovine brain and Flavobacterium. Year Published: 1986
36. Isolation and amino acid sequence of a peptide containing an epoxide-reactive residue from the thermolysin-digest of Scytalidium lignicolum acid protease B. Year Published: 1986
37. Cloning and expression of subtilisin amylosacchariticus gene. Year Published: 1988
School of Pharmaceutical Sciences, Nagasaki University.
38. Cloning and expression of aminopeptidase P gene from Escherichia coli HB101 and characterization of expressed enzyme. Year Published: 1989
School of Pharmaceutical Sciences, Nagasaki University.
39. Thiazolidine derivatives as potent inhibitors specific for prolyl endopeptidase. Year Published: 1989
School of Pharmaceutical Sciences, Nagasaki University.
40. Studies on prolyl endopeptidase from shakashimeji (Lyophyllum cinerascens): purification and enzymatic properties. Year Published: 1989
School of Pharmaceutical Sciences, Nagasaki University.
41. Sequencing and high expression of aminopeptidase P gene from Escherichia coli HB101. Year Published: 1989
School of Pharmaceutical Sciences, Nagasaki University.
42. Chemical modification of neutral protease from Bacillus subtilis var. amylosacchariticus with tetranitromethane: assignment of tyrosyl residues nitrated. Year Published: 1990
School of Pharmaceutical Sciences, Nagasaki University.
43. Purification and characterization of an extracellular prolyl endopeptidase from Agaricus bisporus. Year Published: 1990
School of Pharmaceutical Sciences, Nagasaki University.
44. Protease II from Escherichia coli: sequencing and expression of the enzyme gene and characterization of the expressed enzyme. Year Published: 1992
School of Pharmaceutical Sciences, Nagasaki University.
45. Prolyl endopeptidase from Flavobacterium meningosepticum: cloning and sequencing of the enzyme gene. Year Published: 1992
School of Pharmaceutical Sciences, Nagasaki University.
46. Zinc protease of Bacillus subtilis var. amylosacchariticus: construction of a three-dimensional model and comparison with thermolysin. Year Published: 1993
School of Pharmaceutical Sciences, Nagasaki University.
47. Pyroglutamyl peptidase gene from Bacillus amyloliquefaciens: cloning, sequencing, expression, and crystallization of the expressed enzyme. Year Published: 1993
School of Pharmaceutical Sciences, Nagasaki University.
48. Prolyl endopeptidase from Aeromonas hydrophila: cloning, sequencing, and expression of the enzyme gene, and characterization of the expressed enzyme. Year Published: 1993
School of Pharmaceutical Sciences, Nagasaki University.
49. Isolation and characterization of the prolyl aminopeptidase gene (pap) from Aeromonas sobria: comparison with the Bacillus coagulans enzyme. Year Published: 1995
School of Pharmaceutical Sciences, Nagasaki University.
50. Prolyl aminopeptidase is not a sulfhydryl enzyme: identification of the active serine residue by site-directed mutagenesis. Year Published: 1995
School of Pharmaceutical Sciences, Nagasaki University.
51. Protease II from Moraxella lacunata: cloning, sequencing, and expression of the enzyme gene, and crystallization of the expressed enzyme. Year Published: 1995
School of Pharmaceutical Sciences, Nagasaki University.
52. Prolyl aminopeptidase is also present in Enterobacteriaceae: cloning and sequencing of the Hafnia alvei enzyme-gene and characterization of the expressed enzyme. Year Published: 1996
School of Pharmaceutical Sciences, Nagasaki University.
53. Dipeptidyl peptidase IV from Xanthomonas maltophilia: sequencing and expression of the enzyme gene and characterization of the expressed enzyme. Year Published: 1997
School of Pharmaceutical Sciences, Nagasaki University. t-kabashima@cc.nagasaki-u.ac.jp
54. Prolyl aminopeptidase from Serratia marcescens: cloning of the enzyme gene and crystallization of the expressed enzyme. Year Published: 1998
School of Pharmaceutical Sciences, Nagasaki University, Nagasaki. t-kabashima @cc.nagasaki-u.ac.jp
55. Roles of the Ser146, Tyr159, and Lys163 residues in the catalytic action of 7alpha-hydroxysteroid dehydrogenase from Escherichia coli. Year Published: 1998
School of Pharmaceutical Sciences, Nagasaki University, Nagasaki, 852-8521, Japan.
56. Crystal structure of prolyl aminopeptidase from Serratia marcescens. Year Published: 2000
School of Pharmaceutical Sciences, Nagasaki University, Nagasaki, 852-8521, Japan. t-yoshimoto@cc.nagasaki-u.ac.jp
57. Novel prolyl tri/tetra-peptidyl aminopeptidase from Streptomyces mobaraensis: substrate specificity and enzyme gene cloning. Year Published: 2004
Institute of Life Sciences, Ajinomoto Co., Inc., Kawasaki 210-8681, Japan. yukiko_umezawa@ajinomoto.com
58. Differential gene expression in ACTH -secreting and non-functioning pituitary tumors. Year Published: 2007
Department of Clinical and Molecular Endocrinology, Tokyo Medical and Dental University Graduate School, 1-5-45, Yushima, Bunkyo-ku, Tokyo, Japan, Departments of Pathology and Hypothalamic and Pituitary Surgery, Toranomon Hospital, Tokyo, Japan.
59. Differential gene expression in ACTH -secreting and non-functioning pituitary tumors. Year Published: 2007
Department of Clinical and Molecular Endocrinology, Tokyo Medical and Dental University Graduate School, 1-5-45, Yushima, Bunkyo-ku, Tokyo, Japan. ttateno.cme@tmd.ac.jp
60. High-resolution analysis of DNA copy number alterations and gene expression in renal clear cell carcinoma. Year Published: 2007
Department of Molecular Pathology, Faculty of Medicine, Oita University, Oita, Japan.
61. Prevalence and clinicoepidemiological features of moyamoya disease in Japan: findings from a nationwide epidemiological survey. Year Published: 2007
Division of Epidemiology, Department of Public Health and Forensic Medicine, Tohoku University Graduate School of Medicine, 2-1, Seiryo-machi, Aoba-ku, Sendai, 980-8575, Japan. kuriyama-thk@umin.ac.jp
62. Differential gene expression in ACTH -secreting and non-functioning pituitary tumors. Year Published: 2007
Department of Clinical and Molecular Endocrinology, Tokyo Medical and Dental University Graduate School, 1-5-45, Yushima, Bunkyo-ku, Tokyo, Japan. ttateno.cme@tmd.ac.jp
63. Novel Inhibitor for Prolyl Tripeptidyl Aminopeptidase from Porphyromonas gingivalis and Details of Substrate-recognition Mechanism. Year Published: 2007
Graduate School of Biomedical Sciences, Nagasaki University, 1-14 Bunkyo-machi, Nagasaki 852-8521, Japan.
64. Novel inhibitor for prolyl tripeptidyl aminopeptidase from Porphyromonas gingivalis and details of substrate-recognition mechanism. Year Published: 2007
Graduate School of Biomedical Sciences, Nagasaki University, 1-14 Bunkyo-machi, Nagasaki 852-8521, Japan.
65. Prevalence and clinicoepidemiological features of moyamoya disease in Japan: findings from a nationwide epidemiological survey. Year Published: 2007
Division of Epidemiology, Department of Public Health and Forensic Medicine, Tohoku University Graduate School of Medicine, 2-1, Seiryo-machi, Aoba-ku, Sendai, 980-8575, Japan. kuriyama-thk@umin.ac.jp.
66. Infantile spasms with predominantly unilateral cerebral abnormalities. Year Published: 1995
Department of Pediatrics, Tokushima University School of Medicine, Japan.
67. High-resolution analysis of DNA copy number alterations and gene expression in renal clear cell carcinoma. Year Published: 2007
Department of Molecular Pathology, Faculty of Medicine, Oita University, Oita, Japan.
68. Novel inhibitor for prolyl tripeptidyl aminopeptidase from Porphyromonas gingivalis and details of substrate-recognition mechanism. Year Published: 2007
Graduate School of Biomedical Sciences, Nagasaki University, 1-14 Bunkyo-machi, Nagasaki 852-8521, Japan.
69. Infantile spasms with predominantly unilateral cerebral abnormalities. Year Published: 1995
Department of Pediatrics, Tokushima University School of Medicine, Japan.
70. High-resolution analysis of DNA copy number alterations and gene expression in renal clear cell carcinoma. Year Published: 2007
Department of Molecular Pathology, Faculty of Medicine, Oita University, Oita, Japan.
71. PTEN gene mutation and high MIB-1 labeling index may contribute to dissemination in patients with glioblastoma. Year Published: 2003
Department of Neurosurgery, Tohoku University Graduate School of Medicine, Sendai, Japan.
72. Neuromagnetic separation of secondarily bilateral synchronized spike foci: report of three cases. Year Published: 2004
Neurology Department, Neurologic Institute, Taipei Veterans General Hospital, Taipei, Taiwan.
73. Preoperative visualization of microvascular compression of cranial nerve IX using constructive interference in steady state magnetic resonance imaging in glossopharyngeal neuralgia. Year Published: 2004
Department of Neurosurgery, Tohoku University Graduate School of Medicine, Aoba-ku, Sendai, Japan. karibe@nsg.med.tohoku.ac.jp
74. A cysteine residue near the propionate side chain of heme is the radical site in ascorbate peroxidase. Year Published: 2008
Graduate School of Science and Technology, Kyoto Institute of Technology, Japan.
75. Prevalence and clinicoepidemiological features of moyamoya disease in Japan: findings from a nationwide epidemiological survey. Year Published: 2007
Division of Epidemiology, Department of Public Health and Forensic Medicine, Tohoku University Graduate School of Medicine, 2-1, Seiryo-machi, Aoba-ku, Sendai, 980-8575, Japan. kuriyama-thk@umin.ac.jp
76. Comparison of injectable calcium phosphate bone cement grafting and open flap debridement in periodontal intrabony defects: a randomized clinical trial. Year Published: 2008
Department of Periodontology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan. syoshi@denta.hal.kagoshima-u.ac.jp
77. Aldosterone-stimulated SGK1 activity mediates profibrotic signaling in the mesangium. Year Published: 2008
Department of Blood Purification and Nephrology, Tokyo Medical and Dental University, 5-45, Yushima 1-chome, Bunkyo-ku, Tokyo 113-8519, Japan. yterada.kid@tmd.ac.jp
78. Aldosterone-stimulated SGK1 activity mediates profibrotic signaling in the mesangium. Year Published: 2008
Department of Blood Purification and Nephrology, Tokyo Medical and Dental University, 5-45, Yushima 1-chome, Bunkyo-ku, Tokyo 113-8519, Japan. yterada.kid@tmd.ac.jp
79. Interleukin-27 directly induces differentiation in hematopoietic stem cells. Year Published: 2008
80. Y5U multilayer ceramic capacitors with high-specific capacitance and low-equivalent series resistance. Year Published: 2008
NEC Corp., Kawasaki.
81. Aldosterone Induces Superoxide Generation via Rac1 Activation in Endothelial Cells. Year Published: 2008
Department of Clinical and Molecular Endocrinology, Tokyo Medical and Dental University Graduate School, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8513, Japan. tyoshimoto.cme@tmd.ac.jp.
82. STAT3 Is Indispensable to IL-27-Mediated Cell Proliferation but Not to IL-27-Induced Th1 Differentiation and Suppression of Proinflammatory Cytokine Production. Year Published: 2008
Intractable Immune System Disease Research Center and.
83. Correlation between choline level measured by proton MR spectroscopy and Ki-67 labeling index in gliomas. Year Published: 2000
Department of Neurosurgery, Kohnan Hospital, Sendai, Japan.
84. Serial follow-up MR imaging after gamma knife radiosurgery for vestibular schwannoma. Year Published: 2001
Department of Neurosurgery, Tohoku University School of Medicine, Sendai, Japan.
85. Brain single-photon emission CT studies using 99mTc-HMPAO and 99mTc-ECD early after recanalization by local intraarterial thrombolysis in patients with acute embolic middle cerebral artery occlusion. Year Published: 2001
Department of Neurosurgery and the Cyclotron Research Center, Iwate Medical University, Morioka, Japan.
86. Hemodynamic analysis of an adult vein of Galen aneurysm malformation by use of 3D image-based computational fluid dynamics. Year Published: 2003
Department of Neuroendovascular Therapy, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai 980-8574, Japan. Tamer@rainbow.ifs.tohoku.ac.jp
87. Computational simulation of therapeutic parent artery occlusion to treat giant vertebrobasilar aneurysm. Year Published: 2004
Department of Neuroendovascular Therapy, Tohoku University Graduate School of Medicine, Shock Wave Research Center, Sendai, Japan.
88. Noninvasive evaluation of malignancy of brain tumors with proton MR spectroscopy. Year Published: 1996
Department of Neurosurgery, Tohoku University School of Medicine, Sendai, Japan.
89. Sequential assessment of cerebral blood flow in diffuse brain injury by 123I-iodoamphetamine single-photon emission CT. Year Published: 1998
Department of Neurosurgery, Sendai City Hospital, Japan.
90. 99mTc-bicisate and 99mTc-HMPAO SPECT imaging in early spontaneous reperfusion of cerebral embolism. Year Published: 1999
Department of Neurosurgery, Kohnan Hospital, Japan.
91. Developmental changes of cerebral blood flow and oxygen metabolism in children. Year Published: 1999
Department of Neurosurgery, Tohoku University School of Medicine, Sendai, Japan.
92. Metabolic fates of 2'-deoxy-5-[18F]fluorouridine in tumor-bearing mice and human plasma. Year Published: 1991
Division of Radiopharmaceutical Chemistry, Tohoku University, Sendai, Japan.
93. Interleukin-27 directly induces differentiation in hematopoietic stem cells. Year Published: 2008
Laboratory of Stem Cell Therapy, Center for Experimental Medicine, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
94. SREBP-1c, regulated by the insulin and AMPK signaling pathways, plays a role in nonalcoholic fatty liver disease. Year Published: 2008
Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
95. Platelet-type 12-lipoxygenase accelerates tumor promotion of mouse epidermal cells through enhancement of cloning efficiency. Year Published: 2008
Division of Genetics, Cancer Research Institute, Graduate School of Medicine, Kanazawa University, Kanazawa 920-0934, Japan.